CLINICAL_TRIALS
trial_result
· 2013-05-29
Clinical Trial Update: A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 safety and efficacy data for canagliflozin in older adults (55-80) with Type 2 diabetes have been completed. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-05-29